non-evidence based, or off-label, prescribing which has fueled testosterone use over the previous decade, according to IMS Health sales data. The FDA aims to curb overprescribing by doctors, and the associated potential increased risk of heart attacks
the IPO front, the quarter saw the debut of, among others, Ally Financial ALLY, GoPro GPRO, JD.com JD, and IMS Health IMS . The notable S-1 filings in the quarter included Chinese e-commerce giant Alibaba and GoDaddy. Sector-by
estimates, December 2013 9 Source: McKinsey analysis, September 2012 10 Source: Citi Research, Business Monitor International, IMS , Pharma Database, National Bureau of Statistics of China, December 2013 Note: Not all products, materials or services available
(Reuters) - Shares of TPG Capital Management-backed IMS Health Holdings Inc rose as much as 14 percent in their trading debut, valuing the healthcare information company at up to $7.55 billion.
April 3 (Reuters) - IMS Health Holdings Inc, TPG Capital Management-backed healthcare information company, said its initial public offering was priced at $20 per share, valuing the company at about...
IMS Health is on the right track for growth.
NEW YORK, Dec 17 (Reuters) - IMS Health Inc has hired JPMorgan Chase & Co Inc to lead a proposed initial public offering that could value the private equity-owned healthcare information company at...
landscape. Perhaps the most forceful is the rise in mobility, resulting in greater connectivity to the Internet. According to IMS Research, the number of devices connected to the Internet is expected to climb from roughly 10 billion at the end of 2012 to 28 billion by the end of 2020. 3 <PAGEBREAK>This proliferation is exponentially expanding
market share by volume in these countries. The insulin market is dominated by Novo, Sanofi, and Eli Lilly. According to IMS , these three key players control over 90% of the world's total insulin volume, while 40-plus other players--including
growth is heating up in the emerging nations. The emerging nations currently account for 20% of all drug sales, according to IMS Health. And it’s forecast that drug sales there will rise 85% by 2016, to $359 billion from $194 billion in 2011; that